• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

m6A修饰与癌症之间的联系。

Link Between m6A Modification and Cancers.

作者信息

Liu Zhen-Xian, Li Li-Man, Sun Hui-Lung, Liu Song-Mei

机构信息

Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.

Department of Chemistry and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, University of Chicago, Chicago, IL, United States.

出版信息

Front Bioeng Biotechnol. 2018 Jul 13;6:89. doi: 10.3389/fbioe.2018.00089. eCollection 2018.

DOI:10.3389/fbioe.2018.00089
PMID:30062093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6055048/
Abstract

N6-methyladenosine (m6A) epitranscriptional modification has recently gained much attention. Through the development of m6A sequencing, the molecular mechanism and importance of m6A have been revealed. m6A is the most abundant internal modification in higher eukaryotic mRNAs, which plays crucial roles in mRNA metabolism and multiple biological processes. In this review, we introduce the characteristics of m6A regulators, including "writers" that create m6A mark, "erasers" that show demethylation activity and "readers" that decode m6A modification to govern the fate of modified transcripts. Moreover, we highlight the roles of m6A modification in several common cancers, including solid and non-solid tumors. The regulators of m6A exert enormous functions in cancer development, such as proliferation, migration and invasion. Especially, with the underlying mechanisms being uncovered, m6A and its regulators are expected to be the targets for the diagnosis and treatment of cancers.

摘要

N6-甲基腺苷(m6A)表观转录修饰最近备受关注。通过m6A测序技术的发展,m6A的分子机制及其重要性已被揭示。m6A是高等真核生物mRNA中最丰富的内部修饰,在mRNA代谢及多种生物学过程中发挥关键作用。在本综述中,我们介绍了m6A调控因子的特征,包括产生m6A标记的“书写者”、具有去甲基化活性的“擦除者”以及解码m6A修饰以决定修饰转录本命运的“阅读者”。此外,我们着重阐述了m6A修饰在几种常见癌症中的作用,包括实体瘤和非实体瘤。m6A的调控因子在癌症发展过程中发挥着巨大作用,如增殖、迁移和侵袭。特别是,随着潜在机制的不断揭示,m6A及其调控因子有望成为癌症诊断和治疗的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/a898e7e3502e/fbioe-06-00089-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/c77833cd01c5/fbioe-06-00089-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/e339ca997945/fbioe-06-00089-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/b4b0baa845da/fbioe-06-00089-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/a898e7e3502e/fbioe-06-00089-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/c77833cd01c5/fbioe-06-00089-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/e339ca997945/fbioe-06-00089-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/b4b0baa845da/fbioe-06-00089-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c1/6055048/a898e7e3502e/fbioe-06-00089-g0004.jpg

相似文献

1
Link Between m6A Modification and Cancers.m6A修饰与癌症之间的联系。
Front Bioeng Biotechnol. 2018 Jul 13;6:89. doi: 10.3389/fbioe.2018.00089. eCollection 2018.
2
Role of m6A writers, erasers and readers in cancer.m6A甲基化修饰的写入器、擦除器和读取器在癌症中的作用。
Exp Hematol Oncol. 2022 Aug 9;11(1):45. doi: 10.1186/s40164-022-00298-7.
3
The functions of N6-methyladenosine modification in lncRNAs.N6-甲基腺苷修饰在长链非编码RNA中的功能。
Genes Dis. 2020 Mar 19;7(4):598-605. doi: 10.1016/j.gendis.2020.03.005. eCollection 2020 Dec.
4
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.RNA N6-甲基腺嘌呤修饰在胰腺癌中的新兴作用
Front Oncol. 2022 Jul 22;12:927640. doi: 10.3389/fonc.2022.927640. eCollection 2022.
5
Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.m6A 与癌症中编码/非编码 RNA 的串扰及其修饰残基的检测方法。
Aging (Albany NY). 2023 Jul 11;15(13):6577-6619. doi: 10.18632/aging.204836.
6
Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.主要的N6-甲基腺苷识别蛋白:癌症中的YTH家族蛋白
Front Oncol. 2021 Apr 13;11:635329. doi: 10.3389/fonc.2021.635329. eCollection 2021.
7
Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.RNA的可逆N6-甲基腺苷:基因表达调控机制及其在生理和病理中的意义
Genes Dis. 2020 Jul 6;7(4):585-597. doi: 10.1016/j.gendis.2020.06.011. eCollection 2020 Dec.
8
The Roles of RNA N6-methyladenosine Modifications in Systemic Lupus Erythematosus.RNA N6-甲基腺嘌呤修饰在系统性红斑狼疮中的作用
Cell Biochem Biophys. 2024 Dec;82(4):3223-3234. doi: 10.1007/s12013-024-01464-w. Epub 2024 Aug 2.
9
Comprehensive Analysis of Expression Regulation for RNA m6A Regulators With Clinical Significance in Human Cancers.对在人类癌症中具有临床意义的RNA m6A调节因子的表达调控进行综合分析。
Front Oncol. 2021 Feb 23;11:624395. doi: 10.3389/fonc.2021.624395. eCollection 2021.
10
The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma.N6-甲基腺嘌呤(m6A)修饰在食管癌中的意义。
Mol Biol Rep. 2023 Oct;50(10):8691-8703. doi: 10.1007/s11033-023-08575-2. Epub 2023 Aug 20.

引用本文的文献

1
Epigenetic Modifications in Osteosarcoma: Mechanisms and Therapeutic Strategies.骨肉瘤中的表观遗传修饰:机制与治疗策略
Life (Basel). 2025 Jul 28;15(8):1202. doi: 10.3390/life15081202.
2
Enhancer regulation in cancer: from epigenetics to mA RNA modification.癌症中的增强子调控:从表观遗传学到 mA RNA 修饰
Arch Pharm Res. 2025 Aug 19. doi: 10.1007/s12272-025-01561-1.
3
Advances in research on RNA methylation and cancer radiotherapy resistance.RNA甲基化与癌症放疗抗性的研究进展

本文引用的文献

1
Human C-to-U Coding RNA Editing Is Largely Nonadaptive.人类 C 到 U 的编码 RNA 编辑在很大程度上是非适应性的。
Mol Biol Evol. 2018 Apr 1;35(4):963-969. doi: 10.1093/molbev/msy011.
2
N6-methyladenosine links RNA metabolism to cancer progression.N6-甲基腺苷将 RNA 代谢与癌症进展联系起来。
Cell Death Dis. 2018 Jan 26;9(2):124. doi: 10.1038/s41419-017-0129-x.
3
Tumor treating fields: a new approach to glioblastoma therapy.肿瘤治疗电场:胶质母细胞瘤治疗的新方法。
Front Oncol. 2025 Jul 31;15:1596541. doi: 10.3389/fonc.2025.1596541. eCollection 2025.
4
The Biological Role of LRPPRC in Human Cancers.LRPPRC在人类癌症中的生物学作用
Cancer Control. 2025 Jan-Dec;32:10732748251353077. doi: 10.1177/10732748251353077. Epub 2025 Jun 30.
5
Comprehensive Analysis of Differences in N6-Methyladenosine RNA Methylation Groups in CVB3-Induced Viral Myocarditis and Identification of the Anti-Apoptotic Role of RBM15B.柯萨奇病毒B3诱导的病毒性心肌炎中N6-甲基腺苷RNA甲基化组差异的综合分析及RBM15B抗凋亡作用的鉴定
J Inflamm Res. 2025 Jun 17;18:7933-7949. doi: 10.2147/JIR.S503823. eCollection 2025.
6
Bladder Cancer Growth is Inhibited by Upregulating CircFUT8 through the METTL14/FMR1 Signaling Pathway.通过METTL14/FMR1信号通路上调CircFUT8可抑制膀胱癌生长。
Cell Biochem Biophys. 2025 Jun 10. doi: 10.1007/s12013-025-01794-3.
7
Switching from messenger RNAs to noncoding RNAs, is a novel colorectal cancer diagnosis and treatment target.从信使核糖核酸转向非编码核糖核酸,是一种新型的结直肠癌诊断和治疗靶点。
World J Gastrointest Oncol. 2025 May 15;17(5):104076. doi: 10.4251/wjgo.v17.i5.104076.
8
METTL16 Contributes to Coronary Heart Disease by Inducing TET2 m6A Modification.METTL16通过诱导TET2的m6A修饰促进冠心病。
J Inflamm Res. 2025 May 27;18:6821-6830. doi: 10.2147/JIR.S487828. eCollection 2025.
9
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review).睾丸生殖细胞肿瘤中顺铂敏感性和耐药性的机制及潜在治疗药物(综述)
Exp Ther Med. 2025 Feb 24;29(4):82. doi: 10.3892/etm.2025.12832. eCollection 2025 Apr.
10
Molecular mechanisms of m6A modifications regulating tumor radioresistance.m6A修饰调控肿瘤放射抗性的分子机制
Mol Med. 2025 Feb 19;31(1):64. doi: 10.1186/s10020-025-01121-9.
J Neurooncol. 2018 May;137(3):447-453. doi: 10.1007/s11060-018-2768-x. Epub 2018 Jan 18.
4
FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation.FTO 通过 mRNA 去甲基化靶向 β-连环蛋白来调节宫颈鳞状细胞癌(CSCC)的放化疗耐药性。
Mol Carcinog. 2018 May;57(5):590-597. doi: 10.1002/mc.22782. Epub 2018 Feb 1.
5
Precision therapy for acute myeloid leukemia.精准治疗急性髓系白血病。
J Hematol Oncol. 2018 Jan 5;11(1):3. doi: 10.1186/s13045-017-0543-7.
6
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA mA Modification.METTL14 通过 mRNA mA 修饰抑制造血干/祖细胞分化并促进白血病发生。
Cell Stem Cell. 2018 Feb 1;22(2):191-205.e9. doi: 10.1016/j.stem.2017.11.016. Epub 2017 Dec 28.
7
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/mA/MYC/CEBPA Signaling.R-2HG 通过靶向 FTO/mA/MYC/CEBPA 信号通路发挥抗肿瘤活性。
Cell. 2018 Jan 11;172(1-2):90-105.e23. doi: 10.1016/j.cell.2017.11.031. Epub 2017 Dec 14.
8
Reduced mA mRNA methylation is correlated with the progression of human cervical cancer.mA mRNA甲基化水平降低与人类宫颈癌的进展相关。
Oncotarget. 2017 Oct 24;8(58):98918-98930. doi: 10.18632/oncotarget.22041. eCollection 2017 Nov 17.
9
The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma.M6A甲基转移酶METTL3:在肾细胞癌中作为肿瘤抑制因子发挥作用。
Oncotarget. 2017 Oct 10;8(56):96103-96116. doi: 10.18632/oncotarget.21726. eCollection 2017 Nov 10.
10
Promoter-bound METTL3 maintains myeloid leukaemia by mA-dependent translation control.与启动子结合的METTL3通过依赖于N6-甲基腺苷(mA)的翻译控制维持髓系白血病。
Nature. 2017 Dec 7;552(7683):126-131. doi: 10.1038/nature24678. Epub 2017 Nov 27.